Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (40)
Mengnan Zhao, Tao Lu, Guoshu Bi, Zhengyang Hu, Jiaqi Liang, Yunyi Bian, Mingxiang Feng & Cheng Zhan. (2023) PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis. Biomedicine & Pharmacotherapy 168, pages 115711.
Crossref
Crossref
Rendy Hosea, Sharon Hillary, Shourong Wu & Vivi Kasim. (2023) Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions. Cancers 15:13, pages 3506.
Crossref
Crossref
Nikhil Chandnani, Vedika Shrirang Choudhari, Rajat Talukdar, Sudeshna Rakshit, Geetha Shanmugam, Shiuli Guchait, Ishika Gupta, Melvin George & Koustav Sarkar. (2023) Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC). Medical Oncology 40:7.
Crossref
Crossref
Jian You, Bei Tao, Lilei Peng, Tangming Peng, Haiping He, Shan Zeng, Jizhong Han, Ligang Chen, Xiangguo Xia, Xiaobo Yang & Chuanhong Zhong. (2022) Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis. Cancer Gene Therapy 30:5, pages 683-693.
Crossref
Crossref
MengNa Li, JianXia Wei, ChangNing Xue, XiangTing Zhou, ShiPeng Chen, LeMei Zheng, YuMei Duan, HongYu Deng, Wei Xiong, FaQing Tang, GuiYuan Li & Ming Zhou. (2023) Dissecting the roles and clinical potential of YY1 in the tumor microenvironment. Frontiers in Oncology 13.
Crossref
Crossref
Yang-Yang LIU, Lin LI, Bei JI, Shi-Long HAO, Xiao-Feng KUANG, Xin-Yun CAO, Jia-Yu YUAN, Zhen-Zhou JIANG, Si-Tong QIAN, Chu-Jing WEI, Jing XU, Xiao-Xing YIN, Qian LU & Ting-Ting YANG. (2022) Jujuboside A ameliorates tubulointerstitial fibrosis in diabetic mice through down-regulating the YY1/TGF-β1 signaling pathway. Chinese Journal of Natural Medicines 20:9, pages 656-668.
Crossref
Crossref
Xinghao Fu, Feihong Ji, Qi He & Xinguang Qiu. (2022) A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets. Journal of Immunology Research 2022, pages 1-23.
Crossref
Crossref
Sylwia Pabian‐Jewuła, Aneta Bragiel‐Pieczonka & Marcin Rylski. (2022) Ying Yang 1 engagement in brain pathology. Journal of Neurochemistry 161:3, pages 236-253.
Crossref
Crossref
Abicumaran Uthamacumaran & Morgan Craig. (2022) Algorithmic reconstruction of glioblastoma network complexity. iScience 25:5, pages 104179.
Crossref
Crossref
Yin-Ling Zhang, Jin-Ling Cao, Ye Zhang, Li Liao, Ling Deng, Shao-Ying Yang, Shu-Yuan Hu, Yan Ning, Fang-Lin Zhang & Da-Qiang Li. (2022) RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression. Medical Oncology 39:4.
Crossref
Crossref
Gustavo Ulises Martinez-Ruiz, Abigail Morales-Sanchez & Angel Francisco Pacheco-Hernandez. (2021) Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells. Stem Cell Reviews and Reports 17:5, pages 1590-1606.
Crossref
Crossref
Qian Wang, Dahai Zheng, Yuhan Li, Ye Zhang, Rui Sui, Yi Chen, Haiyang Liang, Ji Shi, Renlong Pan, Xiaobing Xu & Deyu Sun. (2021) Circular RNA circ_0001588 sponges miR‐211‐5p to facilitate the progression of glioblastoma via up‐regulating YY1 expression. The Journal of Gene Medicine 23:10.
Crossref
Crossref
Chenxi Xu, Yi-Hsuan Tsai, Phillip M GalboJr.Jr., Weida Gong, Aaron J Storey, Yuemei Xu, Stephanie D Byrum, Lingfan Xu, Young E Whang, Joel S Parker, Samuel G Mackintosh, Ricky D Edmondson, Alan J Tackett, Jiaoti Huang, Deyou Zheng, H Shelton Earp, Gang Greg Wang & Ling Cai. (2021) Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer. Nucleic Acids Research 49:9, pages 4971-4988.
Crossref
Crossref
Tania V. Lopez-Perez, Belen Tirado-Rodriguez, Mario Morales-Martinez, Mayra Montecillo-Aguado & Sara Huerta-Yepez. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer
251
268
.
Gabriele Michele, Testa Giuseppe & Hansen Anders. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer
123
147
.
Gustavo Ulises Martinez-Ruiz & Abigail Morales-Sanchez. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer
39
57
.
Yusuf Tutar. (2020) Short Commentary on “Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis, and Therapy”. Current Medicinal Chemistry 27:42, pages 7289-7292.
Crossref
Crossref
Thijs C. J. Verheul, Levi van Hijfte, Elena Perenthaler & Tahsin Stefan Barakat. (2020) The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Nadire Özenver & Thomas Efferth. 2020. Prognostic and Therapeutic Applications of RKIP in Cancer. Prognostic and Therapeutic Applications of RKIP in Cancer
357
387
.
Sailu Sarvagalla, Srinivasa Prasad Kolapalli & Sivakumar Vallabhapurapu. (2019) The Two Sides of YY1 in Cancer: A Friend and a Foe. Frontiers in Oncology 9.
Crossref
Crossref
Nikos Malissovas, Elpinickie Ninou, Artemis Michail & Panagiotis K. Politis. (2019) Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis and Therapy. Current Medicinal Chemistry 26:30, pages 5649-5663.
Crossref
Crossref
Emily Hays & Benjamin Bonavida. (2019) YY1 regulates cancer cell immune resistance by modulating PD-L1 expression. Drug Resistance Updates 43, pages 10-28.
Crossref
Crossref
Ishaq N. Khan, Najeeb Ullah, Deema Hussein & Kulvinder S. Saini. (2018) Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications. Seminars in Cancer Biology 52, pages 85-102.
Crossref
Crossref
Levon M. Khachigian. (2018) The Yin and Yang of YY1 in tumor growth and suppression. International Journal of Cancer 143:3, pages 460-465.
Crossref
Crossref
Charalabos Pothoulakis, Monica Torre-Rojas, Marco A. Duran-Padilla, Jonathan Gevorkian, Odysseas Zoras, Emmanuel Chrysos, George Chalkiadakis & Stavroula Baritaki. (2018) CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis. International Journal of Cancer 142:2, pages 334-346.
Crossref
Crossref
Yong Gao, Laisheng Sun, Zicheng Wu, Chengmin Xuan, Junxia Zhang, Yongping You & Xincheng Chen. (2017) miR‑218 inhibits the proliferation of human glioma cells through downregulation of Yin Yang 1. Molecular Medicine Reports.
Crossref
Crossref
Si-Yao Qu, Yuan-Yuan Sun, Yun-Hui Li, Zhen-Ming Xu & Wei-Neng Fu. (2017) YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress. Cancer Medicine 6:6, pages 1389-1398.
Crossref
Crossref
Jinpiao Lin, Yujue He, Junmin Chen, Zhiyong Zeng, Bin Yang & Qishui Ou. (2017) A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6. Journal of Autoimmunity 77, pages 67-75.
Crossref
Crossref
Stephanie Wottrich, Samantha Kaufhold, Emmanuel Chrysos, Odysseas Zoras, Stavroula Baritaki & Benjamin Bonavida. (2017) Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer. Drug Resistance Updates 30, pages 28-38.
Crossref
Crossref
Yongsheng Li, Tingting Shao, Chunjie Jiang, Jing Bai, Zishan Wang, Jinwen Zhang, Lili Zhang, Zheng Zhao, Juan Xu & Xia Li. (2015) Construction and analysis of dynamic transcription factor regulatory networks in the progression of glioma. Scientific Reports 5:1.
Crossref
Crossref
Karrie Kiang, Xiao-Qin Zhang & Gilberto Leung. (2015) Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis. Cancers 7:3, pages 1406-1424.
Crossref
Crossref
Benjamin Bonavida & Samantha Kaufhold. (2015) Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target. Pharmacology & Therapeutics 150, pages 149-168.
Crossref
Crossref
Jéssica Arribas, Josep Castellví, Ricard Marcos, Carles Zafón & Antonia Velázquez. (2015) Expression of YY1 in Differentiated Thyroid Cancer. Endocrine Pathology 26:2, pages 111-118.
Crossref
Crossref
E. A. Veniaminova & O. E. Zubareva. (2015) The changes in exploratory behavior and Fgf2 gene expression in cells of the rat brain after the early postnatal administration of bacterial lipopolysaccharide. Neurochemical Journal 9:2, pages 127-132.
Crossref
Crossref
Shin-Yi Liu, Ming-Fu Chiang & Yu-Jen Chen. (2014) Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma. Experimental Biology and Medicine 240:3, pages 315-323.
Crossref
Crossref
Maria Smolle, Stefan Uranitsch, Armin Gerger, Martin Pichler & Johannes Haybaeck. (2014) Current Status of Long Non-Coding RNAs in Human Cancer with Specific Focus on Colorectal Cancer. International Journal of Molecular Sciences 15:8, pages 13993-14013.
Crossref
Crossref
Vaishali Kashyap & Benjamin Bonavida. (2014) Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression. Genes & Cancer 5:3-4, pages 71-83.
Crossref
Crossref
Judong Luo, Xifa Zhou, Xin Ge, Pengfei Liu, Jianping Cao, Xujing Lu, Yang Ling & Shuyu Zhang. (2013) Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1. Cancer Science 104:11, pages 1544-1551.
Crossref
Crossref
Matthew E. Hardee, Ariel E. Marciscano, Christina M. Medina-Ramirez, David Zagzag, Ashwatha Narayana, Scott M. Lonning & Mary Helen Barcellos-Hoff. (2012) Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β. Cancer Research 72:16, pages 4119-4129.
Crossref
Crossref
Raed Rizkallah, Karen E. Alexander, Ari Kassardjian, Bernhard Lüscher & Myra M. Hurt. (2011) The Transcription Factor YY1 Is a Substrate for Polo-Like Kinase 1 at the G2/M Transition of the Cell Cycle. PLoS ONE 6:1, pages e15928.
Crossref
Crossref